These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6352627)

  • 1. Penetration of ceftazidime into serum, myometrium, endometrium, salpinges and subcutaneous tissue.
    Daschner FD; Petersen EE; Just HM; Hillemanns HG
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():247-9. PubMed ID: 6352627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic prophylaxis in gynecology: cefoxitin concentrations in serum, myometrium, endometrium and salpinges.
    Daschner F; Petersen E; Langmaack H; Trennhäuser M
    Infection; 1982; 10(6):341-2. PubMed ID: 7152685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of cefotetan into serum, myometrium, endometrium and salpinges.
    Just HM; Petersen EE; Bassler M; Frank U; Daschner FD
    Chemotherapy; 1984; 30(5):305-7. PubMed ID: 6593163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic prevention in gynecology. Concentrations of ceftizoxime in the serum, myometrium, endometrium and fallopian tubes].
    Daschner F; Just HM; Brändle J; Zahn V
    Geburtshilfe Frauenheilkd; 1983 Nov; 43(11):683-5. PubMed ID: 6317510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of cefmenoxime into serum, gynecologic tissues, and heart valves.
    Daschner FD; Petersen EE; Frank U; Hornig D
    Am J Med; 1984 Dec; 77(6A):4-6. PubMed ID: 6097123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and tissue concentrations of ceforanide and cefazolin in women undergoing hysterectomy.
    Souney PF; Fisher S; Tuomala RE; Polk BF; Simpson C
    Chemotherapy; 1988; 34(3):185-90. PubMed ID: 3416659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and tissue concentrations of cefoxitin and cefamandole in women undergoing hysterectomy.
    French MA; Quintiliani R; Nightingale CH; Russo JN
    Obstet Gynecol; 1983 Jan; 61(1):42-7. PubMed ID: 6823348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tissue penetration and clinical effects of ceftazidime in the field of obstetrics and gynecology].
    Ogawa E; Ota H; Maki M
    Jpn J Antibiot; 1983 Dec; 36(12):3476-82. PubMed ID: 6371295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of ceftazidime into human tissue in patients undergoing cardiac surgery.
    Adam D; Reichart B; Williams KJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():269-73. PubMed ID: 6352630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of pelvic tissue concentrations after oral administration of enoxacin.
    Bates SA; Elder MG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():79-85. PubMed ID: 3162905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic tissue levels of cefuroxime.
    Pritchard JM; Elder MG; Kennedy MR
    J Infect; 1981 Jun; 3(2):193-4. PubMed ID: 7185961
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with ceftazidime in obstetrics and gynaecology in Japan.
    Takase Z
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():383-7. PubMed ID: 6352649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of cefonicid into serum, salpinges, cervix and vaginal tissue.
    Goisis M; Grossi F; Soncini R; Gusmitta A
    J Chemother; 1991 Feb; 3(1):28-9. PubMed ID: 2019859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tissue distribution of cefotetan in the field of obstetrics and gynecology].
    Nishino H; Nagamatsu M; Ishii S; Takamatsu S; Saito J; Yamanaka K
    Jpn J Antibiot; 1983 Feb; 36(2):398-407. PubMed ID: 6574265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of pefloxacin into gynaecological tissues.
    Bouvet O; Bressolle F; Courtieu C; Galtier M
    J Antimicrob Chemother; 1992 May; 29(5):579-87. PubMed ID: 1624396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid transcription factor-1 expression in normal gynecologic tissues and its potential significance.
    Niu HL; Pasha TL; Pawel BR; LiVolsi VA; Zhang PJ
    Int J Gynecol Pathol; 2009 Jul; 28(4):301-7. PubMed ID: 19483637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of ceftriaxone in serum and gynecological tissues.
    Daschner FD; Petersen EE; Brändle J; Hillemanns HG
    Chemotherapy; 1983; 29(2):153-5. PubMed ID: 6301774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of cephalosporins to obstetrics and gynecology: transfer of cefazolin and cephalothin to uterine tissue.
    Yamada N; Kido K; Uchida H; Yano J; Sagawa N; Hayashi S
    Am J Obstet Gynecol; 1980 Apr; 136(8):1036-40. PubMed ID: 7369254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic implications of doxycycline and cephalothin concentrations in the female genital tract.
    Whelton A; Blanco LJ; Carter GG; Craig TJ; Bryant HH; Herbst DV; King TM
    Obstet Gynecol; 1980 Jan; 55(1):28-32. PubMed ID: 7352059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on absorption, distribution, metabolism and excretion of ceftazidime in Japan.
    Saito A
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():255-62. PubMed ID: 6352628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.